IP Library Patent Application 10530610
Patent Application
App. No. 10/530,610

Methods for detection of breast cancer

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/530,610
Abstract

The invention relates to a simple screening test for neoplasia, a precancerous condition, or cancer of the breast. A method is described whereby a breast cancer marker is detected in breast fluid. In a particular embodiment, the method involves treating samples of breast fluids with an aldehyde detecting reagent without any prewashing. The appearance in breast fluids of a marker that is detected by an aldehyde detecting reagent, such as a Schiff s reagent, correlates very well with the disease status of the breast cancer subjects from which the fluids were obtained. Screening test kits are also provided.

Claims (45)

1 . A method for detecting neoplasia, a precancerous condition, or cancer of the breast in a subject comprising treating a sample of breast fluid from the subject with an aldehyde detecting reagent where the detection of a change produced by the aldehyde detecting reagent compared to a control is indicative of neoplasia, a precancerous condition, or cancer.

2 . A method of claim 1 comprising the following steps:

a) obtaining a sample of breast fluid from a subject;

b) depositing the sample on a solid support;

c) treating the sample with an aldehyde detecting reagent without any prewashing;

d) detecting a calorimetric change produced in the sample, where detection of a colorimetric change compared to a control is indicative of neoplasia, a precancerous condition, or cancer of the breast.

3 . A method of claim 1 for detecting a neoplasia, a precancerous condition, or cancer of the breast in a subject, which method comprises:

a) obtaining a sample of breast fluid from a subject;

b) depositing the sample on a solid support;

c) treating the sample on the support with a Schiff's reagent without any prewashing; and

d) detecting a colorimetric change resulting from the reaction of the sample and Schiff's reagent wherein a calorimetric change is indicative of neoplasia, a precancerous condition, or cancer of the breast.

4 . (canceled)

5 . A method of claim 1 for detecting the presence of neoplasia, a precancerous condition, or cancer of the breast, which method comprises:

(a) obtaining a sample of breast fluid from the nipple of one or both non-lactating breasts of a subject;

(b) depositing the collected sample on a solid water-insoluble support;

(c) treating the sample on the support with a Schiff's reagent without any prewashing;

(d) washing the sample; and

(e) screening for neoplasia, a precancerous condition, or cancer of the breast by persistent purple coloration produced in the sample.

6 . A method of claim 5 wherein the breast fluid is breast discharge, ductal secretion, or nipple aspirate fluid.

7 . A method of claim 2 wherein the sample containing contains an aldehyde marker associated with breast cancer, and comprising in step d) detecting the presence of the aldehyde marker in the sample.

8 . A method of claim 7 wherein the aldehyde marker is capable of reacting with a Schiff's reagent to produce a colorimetric change.

9 . A method as claimed in claim 7 wherein the aldehyde marker comprises low molecular weight aldehydes that are soluble in water.

10 . (Canceled)

11 . (Canceled)

12 . A method of claim 1 for detecting the presence of neoplasia, a precancerous condition, or cancer of the breast, which method consists essentially of obtaining a sample of breast fluid from the breast of a subject; treating the sample with a Schiff's reagent; and, detecting neoplasia, a precancerous condition, or cancer of the breast based upon the coloration produced in the sample by the treatment.

13 . A method as claimed in claim 12 wherein the coloration is distinguished from other colorations.

14 . A method as claimed in claim 12 wherein the breast fluid is nipple discharge, ductal secretion, nipple aspirate or nipple aspirate fluid.

15 . (Canceled)

16 . (Canceled)

17 . A method as claimed in claim 12 wherein the sample is adsorbed on a water-insoluble substrate.

18 . A method as claimed in claim 17 wherein the water-insoluble substrate is made from polyester fibre or glass fibre fabrics.

19 . A method as claimed in claim 2 wherein the sample is additionally screened for the presence of other markers that are indicators of breast cancer.

20 . (Canceled)

21 . (Canceled)

22 . (Canceled)

23 . A kit for carrying out a method of claim 12 .

24 . A method of claim 1 for detecting the presence of neoplasia, a precancerous condition, or cancer of the breast, which method consists essentially of obtaining a sample of breast fluid from a subject; directly treating the sample with a Schiff's reagent and, detecting neoplasia, a precancerous condition, or cancer of the breast based upon the coloration produced in the sample by the treatment.

25 . A method of claim 1 for detecting the presence of neoplasia, a precancerous condition, or cancer of the breast, which method consists essentially of obtaining a sample of breast fluid from a subject; treating the sample with a Schiff's reagent without a step of adding an enzyme and, detecting neoplasia, a precancerous condition, or cancer of the breast.

26 . A method of claim 25 wherein the enzyme is galactose oxidase and optionally catalase.

27 . A method as claimed in claim 1 comprising:

a) obtaining a sample of breast fluid from a subject;

b) depositing the sample on a solid support;

c) treating the sample with a step consisting essentially of adding a Schiff's reagent; and

e) detecting a calorimetric change resulting from the reaction of aldehyde markers on the sample and Schiff's reagent wherein a calorimetric change is indicative of neoplasia, precancer or cancer of the breast.

28 . A method of claim 7 wherein the aldehyde marker comprises aldehydes derived from plasmalogens.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE CHANGE OF NAME PREVIOUSLY RECORDED AT REEL: 051783 FRAME: 0477. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 10, 2020
From: ATOSSA GENETICS INC.
To: ATOSSA THERAPEUTICS, INC.
Reel/Frame 054372/0976 →
CHANGE OF NAME Recorded Feb 3, 2020
From: ATOSSA GENETICS INC.
To: ATOSSA THERAPEUTICS, INC.
Reel/Frame 051783/0477 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 3, 2006
From: KREPINSKY, JIRI JAN; YEUNG, KA SING; FURRER, RUDOLF
To: SENTINA BIOTECHNOLOGY INCORPORATED
Reel/Frame 017525/0497 →